Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia.

Journal Information

Full Title: Leukemia

Abbreviation: Leukemia

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests HG is a current employee of Roche Pharma AG, Grenzach-Wyhlen, Germany. The other authors declare no competing interests."

Evidence found in paper:

"Funding Open Access funding enabled and organized by Projekt DEAL."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025